Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Analysis of long non-coding RNAs in Aila induced non-small cell lung cancer inhibition

PROVIDER: PRJNA690710 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13386753_1.fastq.gz	Fastqsanger.gz
	SRR13386753_2.fastq.gz	Fastqsanger.gz
	SRR13386754_1.fastq.gz	Fastqsanger.gz
	SRR13386754_2.fastq.gz	Fastqsanger.gz
	SRR13386755_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Homo sapiens

Project description:Characterization and selective incorporation of small non-coding RNAs in non-small cell lung cancer exosomes

| PRJNA400356 | ENA

Homo sapiens

Project description:Novel long non-coding RNAs in breast cancer

| PRJNA318451 | ENA

Microarray analysis of differentially expressed long non-coding RNAs in daidzein-treated lung cancer cells

Project description:Microarray analysis of differentially expressed long non-coding RNAs in daidzein-treated lung cancer cells

| PRJNA750676 | ENA

Characterization and selective incorporation of small non-coding RNAs in non-small cell lung cancer exosomes

Project description:Exosomes play important roles in intercellular communication through the delivery of their cargoes, which include proteins, lipids, and RNAs. Increasingly, multiple studies have reported the association between exosomal small non-coding RNAs and cancer, due to their regulatory functions in gene expression. Hence, analysis of the features of small non-coding RNA expression and their incorporation into exosomes is important for cancer research. Here, we performed deep sequencing to investigate the expression of small RNAs in plasma exosomes from lung adenocarcinoma patients, lung squamous cell carcinoma patients, and healthy controls. We found that 5’ YRNA hY4-derived fragments are significantly upregulated in non-small cell lung cancer (NSCLC) exosomes, and may serve as a novel class of circulating biomarkers for NSCLC diagnosis. We also identified that the RNY4P7 gene on chromosome 2 may not be a pseudogene, because the corresponding transcript hY4 reverse fragment was detected in exosomes and cells. Further, we demonstrated that a panel of small RNAs, including miR-451a and miR-122-5p, may be selectively sorted into NSCLC exosomes. Overall, our studies have indicated a wider range of biological effects in NSCLC that may be mediated by exosomal small RNAs than previously known.

2018-02-14 | GSE103149 | GEO

Long non-coding RNA CRNDE Involved in Resistance to EGFR tyrosine kinase inhibitor in EGFR-mutant Lung Cancer via eIF4A3/MUC1/EGFR Signal.

Project description:Introduction: Overcoming of acquired resistance to EGFR-tyrosine kinase inhibitors (EGFR-TKIs) is an intractable obstacle for many clinical oncologists. The mechanisms of resistance to EGFR-TKIs are very complex. Long non-coding RNAs (lncRNAs) may play an important role in cancer development and metastasis. However, the biological process between lncRNAs and drug resistance to EGFR mutated lung cancer largely unknown. Methods: Osimertinib and afatinib-resistant EGFR-mutated lung cancer cells were established using by a stepwise method. Microarray analysis of non-coding and coding RNAs was performed using parental and resistant EGFR-mutant NSCLC cells. Results: Microarray analysis was evaluated by bioinformatics analysis through medical-industrial collaboration. CRNDE and DGCR5 lncRNAs were highly expressed in EGFR-TKIs-resistant cells. CRNDE binds to eIF4A3 protein, down-regulates eIF4A3 and MUC1 expression, and down-regulates p-EGFR expression. CRNDE inhibition activated the eIF4A3/MUC1/EGFR signaling pathway and apoptotic activity and restored sensitivity to EGFR-TKIs. Conclusions: We identified lncRNA CRNDE associated with resistance to EGFR-TKIs in EGFR-mutant NSCLC cells. CRNDE may be a novel therapeutic target for EGFR mutant NSCLC patients.

2021-04-28 | GSE163913 | GEO

Monitoring the differential expression of miRNAs, tRNAs and tRFs in lung cancer biopsies.

Project description:Translational rate has been deregulated in many cancers through small non-coding RNAs aberrations. Herein we focus on miRNAs, tRNAs and tRFs paterns in lung cancer biopsies.

2023-01-01 | GSE143694 | GEO

Signature of MicroRNAs with Impact on Angiogenesis in Non-Small Cell Lung Cancer

Project description:Angiogenesis is regarded as a hallmark in cancer development, and anti-angiogenic treatment is presently used in non-small cell lung cancer (NSCLC) patients. MicroRNAs (miRs) are small non-coding, endogenous, single stranded RNAs that regulate gene expression. As miRs are relatively stabile and measurable in both tissue and serum, they are potential prognostic and predictive markers. In this study we aimed to identify significant altered miRs related to angiogenesis in NSCLC From a large cohort of 335 NSCLC patients, paraffin-embedded samples from 10 patients with a short disease specific survival (DSS), 10 with a long DSS and 10 normal controls were analyzed.

2011-03-08 | E-GEOD-27705 | biostudies-arrayexpress

Project description:long non-coding RNA LRTOR mediates the osimertinib resistance in non-small cell lung cancer

| PRJNA1156387 | ENA

Comprehensive Analysis of Recurrence-Associated Small Non-Coding RNAs in Esophageal Cancer

Project description:Comprehensive Analysis of Recurrence-Associated Small Non-Coding RNAs in Esophageal Cancer

| PRJNA241157 | ENA

Project description:Long non-coding RNAs regulate adipogenesis

| PRJNA140805 | ENA